showing that shRNA-based POLD2 expression knockdown inhibited glioblastoma development (11), indicating that developing POLD2 inhibitors may provide a potential therapeutic strategy to inhibit the progression of malignancies in future research. Here, POLD2 is linked to glioblastoma.